This section is not available in the published analysis.
Access Bio: Audience
Access Bio specializes in the development and commercialization of in vitro diagnostics technology, focusing on rapid diagnostic tests and molecular diagnostics. Their products aim to improve global health by providing reliable testing solutions for infectious diseases, including COVID-19.